These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37140732)
1. L-carnitine Modulates Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights to Oxidative Stress, Inflammation, Synaptic Plasticity, Liver/brain, and Kidney/brain Axes. Morid OF; Menze ET; Tadros MG; George MY J Neuroimmune Pharmacol; 2023 Sep; 18(3):310-326. PubMed ID: 37140732 [TBL] [Abstract][Full Text] [Related]
2. Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways. Ibrahim SS; Abo Elseoud OG; Mohamedy MH; Amer MM; Mohamed YY; Elmansy SA; Kadry MM; Attia AA; Fanous RA; Kamel MS; Solyman YA; Shehata MS; George MY Neuropharmacology; 2021 Oct; 197():108738. PubMed ID: 34339751 [TBL] [Abstract][Full Text] [Related]
3. N-Acetylcysteine Attenuates the Anxiety-Like Behavior and Spatial Cognition Impairment Induced by Doxorubicin and Cyclophosphamide Combination Treatment in Rats. Kitamura Y; Ushio S; Sumiyoshi Y; Wada Y; Miyazaki I; Asanuma M; Sendo T Pharmacology; 2021; 106(5-6):286-293. PubMed ID: 33352577 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of Juglanin against doxorubicin-induced cognitive impairment in rats: Effect on oxidative, inflammatory and apoptotic machineries. Wei T; Wang L; Tang J; Ashaolu TJ; Olatunji OJ Metab Brain Dis; 2022 Apr; 37(4):1185-1195. PubMed ID: 35138546 [TBL] [Abstract][Full Text] [Related]
5. Alpha-Lipoic Acid Ameliorates Doxorubicin-Induced Cognitive Impairments by Modulating Neuroinflammation and Oxidative Stress via NRF-2/HO-1 Signaling Pathway in the Rat Hippocampus. Lal R; Dharavath RN; Chopra K Neurochem Res; 2023 Aug; 48(8):2476-2489. PubMed ID: 37017891 [TBL] [Abstract][Full Text] [Related]
6. Chemical characterization of the polyphenolic rich fraction of Thunbergia erecta and its therapeutic potential against doxorubicin and cyclophosphamide-induced cognitive impairment in rats. El-Din MIG; George MY; Youssef FS J Ethnopharmacol; 2023 May; 307():116213. PubMed ID: 36708885 [TBL] [Abstract][Full Text] [Related]
8. Ameliorative effect of herbacetin against cyclophosphamide-induced nephrotoxicity in rats via attenuation of oxidative stress, inflammation, apoptosis and mitochondrial dysfunction. Ijaz MU; Mustafa S; Batool R; Naz H; Ahmed H; Anwar H Hum Exp Toxicol; 2022; 41():9603271221132140. PubMed ID: 36198566 [TBL] [Abstract][Full Text] [Related]
10. Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries. El-Agamy SE; Abdel-Aziz AK; Wahdan S; Esmat A; Azab SS Mol Neurobiol; 2018 Jul; 55(7):5727-5740. PubMed ID: 29039023 [TBL] [Abstract][Full Text] [Related]
11. Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation. Ali MA; Menze ET; Tadros MG; Tolba MF Neuropharmacology; 2020 Dec; 181():108334. PubMed ID: 33011199 [TBL] [Abstract][Full Text] [Related]
12. Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. Kuzu M; Kandemir FM; Yildirim S; Kucukler S; Caglayan C; Turk E Biomed Pharmacother; 2018 Oct; 106():443-453. PubMed ID: 29990832 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats. Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614 [TBL] [Abstract][Full Text] [Related]
15. Pioglitazone ameliorates DOX-induced cognitive impairment by mitigating inflammation, oxidative stress, and apoptosis of hippocampal neurons in rats. Alhowail AH Behav Brain Res; 2024 Feb; 457():114714. PubMed ID: 37838244 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of doxorubicin, cyclophosphamide, 5-fluorouracil, and cisplatin on cognitive dysfunction in rats: Delineating the role of inflammation of hippocampal neurons and hypothyroidism. Alotayk LI; Aldubayan MA; Alenezi SK; Anwar MJ; Alhowail AH Biomed Pharmacother; 2023 Sep; 165():115245. PubMed ID: 37523981 [TBL] [Abstract][Full Text] [Related]
17. Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats. Mounier NM; Wahdan SA; Gad AM; Azab SS Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1537-1551. PubMed ID: 33755739 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of NLRP3 alleviated chemotherapy-induced cognitive impairment in rats. Jia L; Zhou Y; Ma L; Li W; Chan C; Zhang S; Zhao Y Neurosci Lett; 2023 Jan; 793():136975. PubMed ID: 36427814 [TBL] [Abstract][Full Text] [Related]
19. The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-α. Ren X; Keeney JTR; Miriyala S; Noel T; Powell DK; Chaiswing L; Bondada S; St Clair DK; Butterfield DA Free Radic Biol Med; 2019 Apr; 134():1-8. PubMed ID: 30593843 [TBL] [Abstract][Full Text] [Related]